300 related articles for article (PubMed ID: 24635525)
21. The recent progress of isoxazole in medicinal chemistry.
Zhu J; Mo J; Lin HZ; Chen Y; Sun HP
Bioorg Med Chem; 2018 Jul; 26(12):3065-3075. PubMed ID: 29853341
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological action of 5-oxo-1,2,4-triazine derivatives.
Modzelewska-Banachiewicz B; Kalabun J
Pharmazie; 1999 Jul; 54(7):503-5. PubMed ID: 10445245
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of a novel class of some 1,3,4-oxadiazole derivatives as antimicrobial agents.
Chikhalia KH; Vashi DB; Patel MJ
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):617-22. PubMed ID: 18642158
[TBL] [Abstract][Full Text] [Related]
24. Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine with potent antitumor and antimicrobial activity.
Cirrincione G; Almerico AM; Barraja P; Diana P; Lauria A; Passannanti A; Musiu C; Pani A; Murtas P; Minnei C; Marongiu ME; La Colla P
J Med Chem; 1999 Jul; 42(14):2561-8. PubMed ID: 10411476
[TBL] [Abstract][Full Text] [Related]
25. Recent developments in biological activities of indanones.
Patil SA; Patil R; Patil SA
Eur J Med Chem; 2017 Sep; 138():182-198. PubMed ID: 28667874
[TBL] [Abstract][Full Text] [Related]
26. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
[TBL] [Abstract][Full Text] [Related]
28. Role of uncondensed 1,2,4-triazine compounds and related heterobicyclic systems as therapeutic agents--a review.
Abdel-Rahman RM
Pharmazie; 2001 Jan; 56(1):18-22. PubMed ID: 11210661
[TBL] [Abstract][Full Text] [Related]
29. Medicinal chemistry discoveries among 1,3,5-triazines: recent advances (2000-2013) as antimicrobial, anti-TB, anti-HIV and antimalarials.
Patel RV; Keum YS; Park SW
Mini Rev Med Chem; 2014; 14(9):768-89. PubMed ID: 24958216
[TBL] [Abstract][Full Text] [Related]
30. 1,3,5-Triazine-based analogues of purine: from isosteres to privileged scaffolds in medicinal chemistry.
Lim FP; Dolzhenko AV
Eur J Med Chem; 2014 Oct; 85():371-90. PubMed ID: 25105925
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
32. Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives.
Sarhan MO; Motaleb MA; Ibrahim IT; Anwar MM; Zaghary WA
Mini Rev Med Chem; 2018; 18(15):1302-1320. PubMed ID: 28971773
[TBL] [Abstract][Full Text] [Related]
33. Bioactive acetylenic metabolites.
Kuklev DV; Domb AJ; Dembitsky VM
Phytomedicine; 2013 Oct; 20(13):1145-59. PubMed ID: 23871125
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Liu H; Long S; Rakesh KP; Zha GF
Eur J Med Chem; 2020 Jan; 185():111804. PubMed ID: 31675510
[TBL] [Abstract][Full Text] [Related]
35. o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity.
Jin GF; Ban HS; Nakamura H; Lee JD
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200261
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.
Khatir ZZ; Irannejad H
Mini Rev Med Chem; 2021; 21(19):2874-2928. PubMed ID: 33719962
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines.
Saleh M; Abbott S; Perron V; Lauzon C; Penney C; Zacharie B
Bioorg Med Chem Lett; 2010 Feb; 20(3):945-9. PubMed ID: 20053565
[TBL] [Abstract][Full Text] [Related]
38. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antimicrobial evaluation and spectroscopic characterization of novel imidazolone, triazole and triazinone derivatives.
Abu-Melha S
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():898-905. PubMed ID: 22796528
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():74-86. PubMed ID: 28615111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
